Beth Faiman, CNP, PhD

• 2007 Founding member of the International Myeloma Foundation Nurse Leadership Board
• 2013 Planned and executed the 1st annual nursing meeting at the 14th International Myeloma Workshop in Kyoto, Japan.
• 2014 PhD 
• See Biographical Sketch 

Case Western Reserve University, PhD 2014

• 2006 Appointed as a Delegate for International Myeloma Foundation Nursing Leadership Board
• 2008 Awarded a T32 Educational Training Grant by the National Institutes of Health/National Institute of Nursing Research
• 2011 Awarded an Oncology Nursing Society Foundation grant for clinical research
• 2011 Awarded the F31 National Research Service Award Training Grant sponsored by the National Institutes of Health/National Institute of Nursing Research
• 2012 Oncology Nursing Society Excellence in Medical Oncology Award
• 2013 Oncology Nursing Society Commendation for Outstanding Achievement for Oncology Nursing Education
• 2019 Distinguished Fellow in the American Academy of Nursing (FAAN) 
• 2022 Faiman was named the Top NP in Hematology/Oncology 
• 2022 Inducted as an inaugural Fellow of Advanced Practice in Oncology (FAPO)
• 2023 Given NP/PA Educator of Distinction Award in Multiple Myeloma  

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2024-11-01, Dr. Faiman has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.